SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-106975
Filing Date
2024-04-23
Accepted
2024-04-23 16:05:55
Documents
17
Period of Report
2024-04-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d815817d8k.htm   iXBRL 8-K 34549
2 EX-4.1 d815817dex41.htm EX-4.1 85586
3 EX-4.2 d815817dex42.htm EX-4.2 73551
4 EX-10.1 d815817dex101.htm EX-10.1 335789
5 EX-99.1 d815817dex991.htm EX-99.1 9181
  Complete submission text file 0001193125-24-106975.txt   812928

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA maia-20240422.xsd EX-101.SCH 2881
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE maia-20240422_lab.xml EX-101.LAB 18738
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE maia-20240422_pre.xml EX-101.PRE 11728
20 EXTRACTED XBRL INSTANCE DOCUMENT d815817d8k_htm.xml XML 3744
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 24864843
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)